Mastitis is the inflammation of mammary glands,often caused by pathogenic microorganisms and physicochemical factors.Mastitis decreases milk production and reduces milk quality,which brings huge economic losses of dairy farming industry.The blood-milk barrier formed by alveolar tight junctions provides important protection for milk integrity and the health of pups.There is some evidence that mastitis leads to losses in blood-milk barrier function are directly contributing to tissue damage of mammary glands.It is suggests that maintaining blood-milk barrier function benefits inflammation.Short-chain fatty acids butyrate has anti-inflammatory,antioxidant and anti-arthritic activities.Recent evidence suggests that sodium butyrate(SB)has exhibited protective activity on disruption of blood-brain barrier and gut barrier.However,the protective effects of SB on the blood-milk barrier and its underlying mechanism remain ill-defined.Here,the protective effects and the molecular basis of action of SB were investigated by assessing alterations in the integrity of the blood-milk barrier and the inflammatory response to LPS.Firstly,we observed the effects of SB on LPS-induced mastitis in mice.The results show that SB decreased LPS-induced disruption in mammary tissues,infiltration of inflammatory cells,MPO activity and the levels of TNF-?,IL-1? and IL-6.Our studies have shown that SB treatment significantly ameliorated mammary tissue injury in LPS-induced mastitis.Secondly,the leakage of FITC-albumin from the interstitial side into the alveolar lumen was observed,following treatment with LPS.Correspondingly,treatment of the mammary glands with SB caused reduced this LPS-induced leakage of FITC-albumin into the alveolar lumen.As recognised,the structure and functional integrity of tight junctions are maintained by the tight junction proteins,Claudins and Occludin.In our experiments,we showed that SB up-regulated the expression of these tight junction-associated proteins.All the results suggest that SB exerts protective effects on the blood-milk barrier in LPS-induced mastitis.Finally,we established LPS-stimulated mouse mammary epithelial cells(m MECs)model to further confirm the protective mechanisms of SB on the blood-milk barrier.Studies in vitro revealed that SB has no effect on viability of the m MECs.SB inhibited LPS-induced inflammatory response by inhibition of the NF-?B signaling pathway and histone deacetylases(HDACs)in LPS-stimulated m MECs.In our model,SB protected against LPS-induced mastitis by preserving blood-milk barrier function and depressing pro-inflammatory responses,suggesting the potential use of SB as a feed additive to protect blood-milk barrier function in mastitis. |